Clinical Trial Update: A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A [Phase 1, Phase 2]

View source ↗

Summary

Biocad reports on a Phase 1/2 study evaluating a single-dose administration of ANB-010 for Hemophilia A. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• ANB-010

Snippet

Sponsor: Biocad | Conditions: Hemophilia A | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING